Anxiety: A Look at Epidemiological Factors and Alternate Treatments
Matthew Halma, Arlette Covarrubias, Edgar Selem, Joseph Varon

Anxiety disorders have become a pressing global concern, with prevalence rates steadily increasing due to factors such as economic stress, lifestyle changes, and major events like the COVID-19 pandemic. This study examines the epidemiological factors influencing anxiety, including demographic trends, socioeconomic status, and modifiable risk factors. Women and young adults are disproportionately affected, with biological and social factors contributing to their heightened vulnerability. Socioeconomic disparities exacerbate anxiety, particularly in marginalized communities where financial insecurity and limited healthcare access prevail. The study also explores the potential of alternative therapies, such as Ashwagandha, CBD, and saffron, which have shown promise in reducing anxiety symptoms through various biochemical pathways. By integrating these alternative treatments with conventional approaches, healthcare professionals can develop personalized interventions to improve mental well-being and quality of life. Understanding the complex interplay between demographic, socioeconomic, and lifestyle factors is crucial for reducing the burden of anxiety disorders and enhancing public health outcomes.
Keywords: Anxiety, Epidemiology, Prevalence, Risk factors, Alternative therapy, Mental health, Neurotransmitters, Biomarkers


